People Finder
- Find a person by name or search via surname initial
  
  Quick search
  - A
  - B
  - C
  - D
  - E
  - F
  - G
  - H
  - I
  - J
  - K
  - L
  - M
  - N
  - O
  - P
  - Q
  - R
  - S
  - T
  - U
  - V
  - W
  - X
  - Y
  - Z

Industries

Practices
- Go to Practices Section

Knowledge Library

Global Directory

Join Us

Events

Search Thought Leadership

To refine your search select a single option or a combination of options:

Find

reset

THOUGHT LEADERSHIP

Displaying Thought Leadership item(s) about Healthcare & Life Sciences

Show 10 | 50 | 100 | All results per page 1/2/3/4/5 Next

217 results

- June 07, 2021
  
  Healthcare & Life Sciences: Drug Pricing Digest
  
  Latham’s Government Price Reporting Team covers general developments, the Medicaid Drug Rebate Program, the 340B Drug Pricing Program, Medicare Part B, and state law developments.
  
  share view
- May 27, 2021
  
  Digital Health 2021
  
  In Lexology’s Getting the Deal Through: Digital Health 2021 (UK) Latham considers the key regulatory and transactional issues faced by market players and practitioners.
  
  share view
- May 24, 2021
  
  Healthcare & Life Sciences: Drug Pricing Digest
  
  Latham’s Government Price Reporting Team covers general developments, the Medicaid Drug Rebate Program, the 340B Drug Pricing Program, Medicare Part B, and state law developments.
  
  share view
- May 10, 2021
  
  Healthcare & Life Sciences: Drug Pricing Digest
  
  Latham’s government price reporting team covers general developments, followed by sections focusing on the Medicaid Drug Rebate Program, the 340B Drug Pricing Program, Medicare Part B, and state law developments.
  
  share view
- March 03, 2021
  
  EU-UK Trade and Cooperation Agreement: Implications for Life Sciences Companies
  
  The agreement provides guidance across several areas for the life sciences sector, though gaps remain.
  
  share view
- February 19, 2021
  
  Life Sciences Law Review - 9th Edition, France Chapter
  
  Latham lawyers Eveline Van Keymeulen and Jeanne Fabre discuss essential rules on medicines and medical devices under the French regulatory regime, for the Life Sciences Law Review.
  
  share view
- January 21, 2021
  
  Biden Administration Update: Potential Impact for Healthcare & Life Sciences
  
  Latham partners discuss the new leadership emerging from the Biden Administration and their expected regulatory and enforcement priorities for the industry.
  
  share view
- December 17, 2020
  
  Antitrust Enforcement in Health Care: A Risky and Evolving Landscape
  
  A cross-country team of litigators examines the US Department of Justice trends in antitrust enforcement in the last 18 months for In Vivo, the premiere resource for life sciences business strategy.
  
  share view
- September 30, 2020
  
  Securities Litigation Trends During Covid-19
  
  In an article for Bloomberg Law, partners Blair Connelly and Colleen Smith and associate Cindy Guan, explore patterns emerging in securities litigation in the age of the pandemic.
  
  share view
- September 25, 2020
  
  UK Issues New Guidance for Medical Device Regulation After Brexit
  
  The MHRA offers new guidance on how medical devices will be regulated in the UK from 1 January 2021.
  
  share view

Show 10 | 50 | 100 | All results per page 1/2/3/4/5 Next

The cookies we use

Latham & Watkins uses cookies which are essential for the operation of our website. We would also like to use analytics cookies to help us understand how visitors use our site so we can continue to improve it, but we will only do so with your consent. We use a cookie to remember your preferences. You can access and change your preferences at any time by clicking on the gear icon.

Essential cookies

Essential cookies enable the core functionality of our website such as security, authentication, and accessibility. You can change your browser settings to disable these cookies, but it may affect your ability to access and use the site.

Analytics cookies

We would like to use Google Analytics to analyse how visitors interact with our site so that we can continue to develop and improve it. These services are provided in Europe by Google Ireland Limited and elsewhere by Google LLC and affiliated Google Entities. Google Analytics uses cookies to collect information about visitors to our site (data related to the device/browser, IP address and on-site activity). They measure and report on user interactions, such as the volume and nature of visits to our site. If you agree to the use of these analytics cookies, please move the slider to “On.” Please refer to the Cookies Policy on our Privacy page for more information.

Latham & Watkins LLP has office locations in Beijing, Boston, Brussels, Century City, Chicago, Dubai, Düsseldorf, Frankfurt, Hamburg, Hong Kong, Houston, London, Los Angeles, Madrid, Milan, Moscow, Munich, New York, Orange County, Paris, Riyadh,* San Diego, San Francisco, Shanghai, Seoul, Silicon Valley, Singapore, Tokyo, and Washington, D.C.
*In cooperation with the Law Office of Salman M. Al-Sudairi